Literature DB >> 28199155

Taking It Off: New Insights into the Role of Tyrosine Phosphorylation-dependent Pathways in the Pathogenesis of Pulmonary Fibrosis.

Gregory P Downey1,2,3,4,5, Yael Aschner6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28199155      PMCID： PMC5378427          DOI： 10.1164/rccm.201609-1921ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  16 in total

1.  SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.

Authors:  Argyrios Tzouvelekis; Guoying Yu; Christian L Lino Cardenas; Jose D Herazo-Maya; Rong Wang; Tony Woolard; Yi Zhang; Koji Sakamoto; Hojin Lee; Jae-Sung Yi; Giuseppe DeIuliis; Nikolaos Xylourgidis; Farida Ahangari; Patty J Lee; Vassilis Aidinis; Erica L Herzog; Robert Homer; Anton M Bennett; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

2.  Loss of Shp2 in alveoli epithelia induces deregulated surfactant homeostasis, resulting in spontaneous pulmonary fibrosis.

Authors:  Xue Zhang; Yun Zhang; Bo Tao; Li Teng; Yanwei Li; Rui Cao; Qiu Gui; Madong Ye; Xiaozhou Mou; Hongqiang Cheng; Hu Hu; Ren Zhou; Ximei Wu; Qiangmin Xie; Wen Ning; Maode Lai; Huahao Shen; Gen-Sheng Feng; Yuehai Ke
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

Review 3.  Idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Annie Pardo; Moisés Selman
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

4.  Regulation of platelet-derived growth factor receptor activation by afadin through SHP-2: implications for cellular morphology.

Authors:  Shinsuke Nakata; Naoyuki Fujita; Yuichi Kitagawa; Ryoko Okamoto; Hisakazu Ogita; Yoshimi Takai
Journal:  J Biol Chem       Date:  2007-10-30       Impact factor: 5.157

5.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

6.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Authors:  Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

Review 7.  Protein tyrosine phosphatases in pathological process.

Authors:  Alicja Kuban-Jankowska; Magdalena Gorska; Narcyz Knap; Francesco Cappello; Michal Wozniak
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

Review 8.  Integrating mechanisms of pulmonary fibrosis.

Authors:  Thomas A Wynn
Journal:  J Exp Med       Date:  2011-07-04       Impact factor: 14.307

9.  Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Authors:  Eric W F W Alton; David K Armstrong; Deborah Ashby; Katie J Bayfield; Diana Bilton; Emily V Bloomfield; A Christopher Boyd; June Brand; Ruaridh Buchan; Roberto Calcedo; Paula Carvelli; Mario Chan; Seng H Cheng; D David S Collie; Steve Cunningham; Heather E Davidson; Gwyneth Davies; Jane C Davies; Lee A Davies; Maria H Dewar; Ann Doherty; Jackie Donovan; Natalie S Dwyer; Hala I Elgmati; Rosanna F Featherstone; Jemyr Gavino; Sabrina Gea-Sorli; Duncan M Geddes; James S R Gibson; Deborah R Gill; Andrew P Greening; Uta Griesenbach; David M Hansell; Katharine Harman; Tracy E Higgins; Samantha L Hodges; Stephen C Hyde; Laura Hyndman; J Alastair Innes; Joseph Jacob; Nancy Jones; Brian F Keogh; Maria P Limberis; Paul Lloyd-Evans; Alan W Maclean; Michelle C Manvell; Dominique McCormick; Michael McGovern; Gerry McLachlan; Cuixiang Meng; M Angeles Montero; Hazel Milligan; Laura J Moyce; Gordon D Murray; Andrew G Nicholson; Tina Osadolor; Javier Parra-Leiton; David J Porteous; Ian A Pringle; Emma K Punch; Kamila M Pytel; Alexandra L Quittner; Gina Rivellini; Clare J Saunders; Ronald K Scheule; Sarah Sheard; Nicholas J Simmonds; Keith Smith; Stephen N Smith; Najwa Soussi; Samia Soussi; Emma J Spearing; Barbara J Stevenson; Stephanie G Sumner-Jones; Minna Turkkila; Rosa P Ureta; Michael D Waller; Marguerite Y Wasowicz; James M Wilson; Paul Wolstenholme-Hogg
Journal:  Lancet Respir Med       Date:  2015-07-03       Impact factor: 30.700

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.